진용환

This profile gathers the share dealings of 진용환 in 삼성바이오로직스. Over a trading history stretching from 6 January 2023 to 27 November 2025, the count stands at 4 filings.

Both buying and selling appear: 2 purchases worth €22k, against 2 sales. The totals do not cover 3 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 1 purchase and 1 sale.

On 27 November 2025 came the latest disclosure, an open-market purchase in 삼성바이오로직스. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.